Participation and survival of geriatric patients in Phase I clinical trials: The Karmanos Cancer Institute (KCI) experience

This study suggests that elderly patients who were treated on a Phase I clinical trial(s) at our institution survived significantly longer than our elderly patients who did not receive treatment.